Dr. John Cush RheumNow
3 years 8 months ago
The First Head to Head trial in Axial SpA
Dr.Gensler discusses abstract L15 presented at #ACR22. L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic AxSpA: A Randomized Phase IIIb Study
https://t.co/RgwKRJwgoS https://t.co/6LxOURICiE
Dr. John Cush RheumNow
3 years 8 months ago
Marginal Benefit with Diet and Exercise in Obese Knee Osteoarthritis Patients
The easiest intervention for knee osteoarthritis (diet and exercise) is also the most difficult for many patients; but do these work?
https://t.co/s4Gzmh2gGZ https://t.co/aZORTMtCvs
Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow and ends with an audience question on "Macro-CK".
Nature Reviews Rheumatology features a review of three notable papers that address the impact of SARS-CoV-2 vaccination on people with inflammatory rheumatic disease.
Dr. John Cush RheumNow
3 years 8 months ago
Get the Skinny on Bimekizumab in PsA
Dr. Janet Pope discusses abstract presented at #ACR22.
https://t.co/FKFARxQ2fa https://t.co/wSyXeSHII3
Dr. John Cush RheumNow
3 years 8 months ago
During 2021–22 FLU season, 6% of hosp pedi-influenza pts had SARS-CoV-2 coinfection; these required more respiratory support. Risk of influenza death augmented by not recv vaccination (flu or covid), no antiviral Rx, comorbidities & coinfx w/COVID https://t.co/bfjeClHflW https://t.co/YTOEnNSQQN
Dr. John Cush RheumNow
3 years 8 months ago
Lupus Research Alliance announced 2022 Distinguished Innovator Award recipients:
- Hongbo Chi, PhD, Exploring Metabolism of Follicular Helper T Cells & Lupus Progression
- Joseph Craft, MD: Processes Enabling T Cells to Be Destructive in Lupus Nephritis
https://t.co/yI2NlCHaBi https://t.co/fevBTkaxCY
Dr. John Cush RheumNow
3 years 8 months ago
#OA phenotypes by SF cell status
- Activated: hi T-cell, low mono–macrop-PMN activated; 70% improved
- Lymphoid: hi PMN, low lymph & mono, low activ, lower pain
- Myeloid: hi NK & mono, low T-cell & activat
- Aggressive: hi lymph/macr/NK/PMN;39%improve
-https://t.co/3DXPoDE5Pm https://t.co/VRJkscAm5a
The occurrence of interstitial lung disease (ILD) in Systemic sclerosis portends serious morbid and mortal outcomes for those affected. This review examines the available clinical literature on the potential benefits and outcomes of JAK inhibitor use in SSc=ILD.
The American College of Rheumatology (ACR) released a summary of its new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis. This is the first ACR guideline about an integrative approach to Rheumatoid Arthritis (RA) and it is considered complementary to the ACR’s 2021 Guideline for the Treatment of RA, which covers pharmacologic therapies.
Dr. John Cush RheumNow
3 years 8 months ago
Comorbidities in Axial Spondyloarthritis
Dr. Antoni Chan discusses Abstract 1609 at ACR22 Convergence.
https://t.co/dCLlgiGV9K https://t.co/a4iI1q3zZC
Dr. John Cush RheumNow
3 years 8 months ago
Will a vegetarian diet and exercise actually help RA disease activity?
https://t.co/NI6xmhN0sO https://t.co/7IlQWkXkE1
Dr. John Cush RheumNow
3 years 8 months ago
A&R: Climate Emergency and the Health of Our Patients
- A public health crisis that will affect Rheum pts
- climate factors can worsen Dz
- Pollution causes autoimmunity
- Climates worse effects on the vulnerable
- Advocacy solutions research are needed https://t.co/JJufiImhND
